What Transformation Has the Autoimmune Disease Diagnosis Market Undergone?
The autoimmune disease diagnosis market has seen considerable growth due to a variety of factors.
• In recent years, the market size for autoimmune disease diagnosis has seen robust growth. The market, valued at $5.84 billion in 2024, is projected to expand to $6.25 billion in 2025, registering a compound annual growth rate (CAGR) of 7.1%.
The past growth can be linked to factors such as the surge in autoimmune diseases, the development of emerging markets, heightened healthcare spending, and a higher occurrence rate in females.
What Is The Forecast For The Autoimmune Disease Diagnosis Market By 2029?
The autoimmune disease diagnosis market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for robust expansion in the autoimmune disease diagnosis market in the coming years, which is projected to reach $8.81 billion by 2029, with a compound annual growth rate (CAGR) of 9.0%.
The projected growth within this period can be linked to factors such as more significant investments in autoimmune (ai) diagnostics, rapid economic growth, heightened consciousness about autoimmune disorders, and the discovery of biomarkers. The forecast period will also likely see key trends like forming strategic alliances with other entities, injecting investments into artificial intelligence businesses, working closely with governmental bodies, and the development of rapid home test kits.
Which Drivers Are Accelerating Growth In The Autoimmune Disease Diagnosis Market?
The rise in autoimmune diseases has fueled the growth of the autoimmune disease diagnosis market. Multiple Sclerosis Australia, an Australian national non-profit organization engaged in research and advocacy for those affected by multiple sclerosis, stated in February 2023 that the number of Multiple Sclerosis patients in Australia reached 33,335 in 2021. This figure marks a 30% (7,728) surge from the previous four years (25,607). Consequently, the escalating prevalence of autoimmune diseases worldwide is propelling the expansion of the autoimmune disease diagnosis market.
How Is The Globa Autoimmune Disease Diagnosis Market Divided Into Key Segments?
The autoimmune disease diagnosis market covered in this report is segmented –
1) By Product: Consumables And Assay Kits, Instruments
2) By End User: Clinical Laboratories, Hospitals, Others
3) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests
Subsegments:
1) By Consumables And Assay Kits: ELISA Kits, Reagents And Test Kits, Sample Collection And Preservation Devices, Control And Calibration Materials
2) By Instruments: Immunoassay Analyzers, Flow Cytometers, Luminometers, Microscopes, Other Diagnostic Devices
Pre-Book The Autoimmune Disease Diagnosis Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Autoimmune Disease Diagnosis Market?
In the autoimmune disease diagnosis sector, biosensors and nano biosensors for quick detection are cutting-edge tools. Popular due to their affordability, high precision, ease of use, multiplexing capabilities, and prompt diagnosis, they measure the amount of antibodies present in human blood serum with remarkable sensitivity. Additionally, they ascertain the activity of antibodies since the analysis uses mobile optical label-free biosensors grounded on spectral correlation interferometry. When compared to traditional diagnosis methods, this point-of-care technology renders a comprehensive, insightful, prompt, and precise diagnosis of autoimmune diseases.
Who Are the Key Players in the Autoimmune Disease Diagnosis Market?
Major companies operating in the autoimmune disease diagnosis market include:
• Siemens Healthineers AG
• Abbott Laboratories
• Thermo Fisher Scientific Inc
• Bio-Rad Laboratories Inc
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• AESKU Diagnostics GmbH & Co. KG
• Trinity Biotech plc.
• bioMérieux SA
• SQI Diagnostics
• SCHILLER Healthcare India Pvt. Ltd
• Covidien Healthcare India Private Limited
• Philips Healthcare India
• Fisher & Paykel Healthcare India Private Limited
• Smith’s Medical India Pvt Ltd
• Agappe Diagnostics Ltd
• Accord Medical Products Private Limited
• Lepu Medical Technology Company (Beijing) Co. Ltd
• Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co. Ltd
• Shanghai Runda Medical Technology Co. Ltd
• GE Healthcare China Co. Ltd
• Roche Holding AG
• Koninklijke Philips
• Theradiag
• Sanofi
• Themis Bioscience
• Becton Dickinson and Company
What are the Regional Insights into the Autoimmune Disease Diagnosis Market?
North America was the largest region in the autoimmune disease diagnosis market in 2024. Western Europe was the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
